Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Apr 06, 2022 7:48pm
98 Views
Post# 34582507

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:So anything good coming out soon

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:So anything good coming out soon

Regardless of numbers, everyone should vote how they believe it should be counted, even if majorities aren't hit.  Many did this last year and I think it does send a message to the Chairwomen and CEO on what shareholders view as the importance of the skills as we see it that the individual Board member may bring.  Shareholders could be completely wrong since we don't read Board minutes, but it's up to the Board and management to change that view.  Last year two members had noticeably lower vote totals.  It sends a message.  I suspect that a will have some impact on the composition this year, and the votes this year should also reflect shareholders ranking of members.  Given there are a few large shareholders they need to answer too, the Board and management should not ignore vote rankings. Everyone should vote as they see it regardless of it actually having an effect this year.  It may matter in the future.  This is still a highly insular Board and they've done nothing to diversify into a global, let alone North American, oriented Board.  I believe there's only Mr Arena who is not part of Canadian biz club and he is part of Pauls biz club .  We need more US rep and outside voices.  I would also love to see Rothenberg as a full Board member if possible.  

 


PWIB123 wrote: I fully understand these things, and it's because I don't believe my vote or anyone elses will truly have an impact that I can throw logic and common sense out the window and vote purely on emotion.  I wouldn't mind sending an aggressive message.  Every one should vote their conscious and mine leads to voting against every one of them.  Here's how firm I am on this at this point.  Even if there is amazing news that comes out between now and then and the stock price exponentially increases, I'm still going to vote against all of them.  They will not get a pass from me on how they've handled the share price issue and investor relations to-date.  I'm not giving them a pass if they get lucky on timing of good news.  There's future issues related to more of the same at stake here and they've ignored meaningful shareholder concerns, such as yours.  So, I hope I can smile and enjoy profiting from a significant rise in share price soon, but I'm not going to give them a pass on how they got there, if they do.

I do really appreciate your feedback and the rationality your using.  In reality though, we can actually vote our emotion and be fairly certain it won't result in any real impact.  I hope they'll notice.  I hope they'll pause to consider how much further it could go.  I hope they'll have to respond to concerns from large shareholders.  I hope all those things happen as a result.  It still reflects on management even if it doesn't change the outcome directly.  
 

SPCEO1 wrote: Some practical points that I think are worth considering on this topic:

1.) One week from right now, we may be feeling a lot better about management. Now it will likely take a little longer than that to find out about the results of the phase 1a trial but we can already be pretty confidentthat something good has happened there that gives us reason to believe TH-1902's longer term prospects may be very intriguing. And who knows, they may talk more directly about patient #2 next week on the conference call.

2.)  If you were to vote everyone off the board,TH would no longer have a board since there is no option to vote someone new onto the board and all board members are  up for elelction each year (no staggered board). That seems less than ideal, no? And who would appoint a new board? I don't know as I have never looked into that but my guess is shareholders might have less a say in that than they should, at least initially.

3.) In order to kick a current board member off the board, you need a majority of the votes cast at the meeting (I am assuming this to be true but I have never delved into it). Since a lot of people do not bother to vote, getting a majority is easier than it seems. But you would need to convince me and some of the people I know well to join you and vote against the BOD if you have any hope of succeeding in dumping the current board. I am not there yet and I don't think my friends are either. But even if you convinced us all, you likley still would not have enough votes to succeed unless you got Soleus or whoever the hedge funds that Morgan Stanley is acting as custodian of their funds. If all of those agreed on a strategy, the board could probably be thrown out. The chances of all thsoe s hareholders agreeing seems very close to zero. Soleus would likely have to lead that effort and they would need to put forward a plan that seemed sensible. I don't know Soleus but my guess is this is not their modus operandi. They would also first have to file with the SEC signalling they are not just a passive shareholder. It seems like if they were planning on such an effort, they would have been talking about it already.

Now, everyone should vote their conscious but just realize the chances of effecting change are not real high at the moment even after the disappointing share price performance since Paul took over two years ago.   

We should be getting the proxy very soon if the meeting is to be held in mid-May as is typical. My guess is the compensation part of that may inflame some emotions as it will once again appear that it is a "heads they win, tails you lose" type of game. While that may be the case, it is just a truism that shareholders normally undervalue the power they do have in such matters, that the odds are stacked against them by the rules surrounding corporate governance and that the board and management therefore can take advantage of that and often do. It is a rare occaision where shareholders rise up and take control and when it happens, it is normally led by a deep pocketed shareholder and not smaller shareholders.

PWIB123 wrote: And another reason why I still intend to vote against every single one of them.  

palinc2000 wrote: You reap what you sow!!!  
There has never been a consistent strategic plan over the company 's history.Tesamorelin was  and still is a great product  imo but for some reason the company did not in the past pursue any development with tesamorelin and only got involved after the Grinspoon study results were released ...and even then maybe the right  decision  then would have been to redo a formal  FDA approved Phase 2 b clinical trial (and by now the results would have been known)
Then THTX gets involved with Trogarzo when by coincidence THTX s representatives meet with Taimed s rep during a Conference on Hiv I think in the US ...Recall that Taimed had been looking for a partner ....To make a long story short THTX ended up with Trogarzo and we know where we stand now,,,,
So three years ago everything looked pretty bleak and it was getting hot in the kitchen and what I felt at the time as being out of desparation or to create a distraction here comes out of the blue the acquisition of Katana  for almost zero .......Katana had been looking for  awhite knight for more than a year,......I dont know how the Katana story will play out but my point is Katana came about not by design as part of a strategic plan but as another try similar to dart throwing or a Lottery ticket The focus here on this board is almost exclusively on the dart game in the hope that they hit the bulls eye!!!

I think today is the 2 nd anniversary of Paul 's joining THTX,,,,I hope he is able to steer the company in the right direction and  with a  clear  plan....and not behave like  jumping bees...Paul still has my vote ......but I would have liked  a shake up of the organizationin the first 6 mos of his tenure








Bucknelly21 wrote: I mean if they hit with cancer then im fine but before this it was nash, i waited, then before that trogarzo, i waited, i blame myself but as a shareholder who stuck with them theough it all i would be nice for an assist from the company 

 

 

 




<< Previous
Bullboard Posts
Next >>